Cargando…

Macrolides and community-acquired pneumonia: is quorum sensing the key?

Combination therapy with two antimicrobial agents is superior to monotherapy in severe community-acquired pneumonia, and recent data suggest that addition of a macrolide as the second antibiotic might be superior to other combinations. This observation requires confirmation in a randomised control t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wise, Matt P, Williams, David W, Lewis, Michael AO, Frost, Paul J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945083/ https://www.ncbi.nlm.nih.gov/pubmed/20663182 http://dx.doi.org/10.1186/cc9084

Ejemplares similares

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2021)

Macrolides as Empiric Therapy for Outpatients With Pneumonia
por: Musher, Daniel M
Publicado: (2021)

The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae
por: Yayan, Josef
Publicado: (2014)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia
por: Copete, Angela Rocio, et al.
Publicado: (2018)

Corticosteroids for community-acquired pneumonia: time to act!
por: Annane, Djillali, et al.
Publicado: (2008)

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

ICU admission and severity assessment in community-acquired pneumonia
por: Chalmers, James D
Publicado: (2009)

Evolution of Microbial Quorum Sensing to Human Global Quorum Sensing: An Insight into How Gap Junctional Intercellular Communication Might Be Linked to the Global Metabolic Disease Crisis
por: Trosko, James E.
Publicado: (2016)

Moving Past the Routine Use of Macrolides—Reviewing the Role of Combination Therapy in Community-Acquired Pneumonia
por: Shumilak, Geoffrey, et al.
Publicado: (2018)

Macrolide resistance in pneumococci—is it relevant?
por: Cheng, Allen C., et al.
Publicado: (2016)

Choosing the right combination therapy in severe community-acquired pneumonia
por: Waterer, Grant W, et al.
Publicado: (2006)

Community-acquired pneumonia in the United Kingdom: a call to action
por: Chalmers, James, et al.
Publicado: (2017)

Silencing quorum sensing and ICE mobility through antiactivation and ribosomal frameshifting
por: Ramsay, Joshua P, et al.
Publicado: (2015)

Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients
por: Aldhahri, Raghad K., et al.
Publicado: (2022)

Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring
por: Kim, Yoonjung, et al.
Publicado: (2022)

A quorum sensing-mediated switch contributes to natural transformation of Vibrio cholerae
por: Blokesch, Melanie
Publicado: (2012)

Acquisition of resistance to carbapenem and macrolide-mediated quorum sensing inhibition by Pseudomonas aeruginosa via ICE(Tn4371)6385
por: Ding, Yichen, et al.
Publicado: (2018)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

The Impact of Viral Infections in Children with Community-Acquired Pneumonia
por: Mameli, Chiara, et al.
Publicado: (2013)

Surfactant protein genetics in community-acquired pneumonia: balancing the host inflammatory state
por: Floros, Joanna, et al.
Publicado: (2011)

Macrolide Resistance in Streptococcus pneumoniae
por: Schroeder, Max R., et al.
Publicado: (2016)

Communication is the key: biofilms, quorum sensing, formation and prevention
por: Preda, Veronica G., et al.
Publicado: (2019)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
por: Domon, Hisanori, et al.
Publicado: (2023)

Quorum Sensing Regulation of Competence and Bacteriocins in Streptococcus pneumoniae and mutans
por: Shanker, Erin, et al.
Publicado: (2017)

Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
por: Gadsby, Naomi J., et al.
Publicado: (2016)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Investigation of LuxS-mediated quorum sensing in Klebsiella pneumoniae
por: Chen, Lijiang, et al.
Publicado: (2020)

Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
por: Warris, Adilia
Publicado: (2021)

Rapid Diagnostic Testing for Community-Acquired Pneumonia: Can Innovative Technology for Clinical Microbiology Be Exploited?
por: Yu, Victor L., et al.
Publicado: (2009)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial
por: Hamao, Nobuyoshi, et al.
Publicado: (2020)

Methicillin-Resistant Staphylococcus aureus and Community-Acquired Pneumonia: An Evolving Relationship
por: Mandell, L. A., et al.
Publicado: (2012)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Bacterial Quorum Sensing and Microbial Community Interactions
por: Abisado, Rhea G., et al.
Publicado: (2018)

Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get
por: Salluh, Jorge IF, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j5b5kiablqk3khbfnk2koikv36